Dr. Peter D. Nicholas III, D.O.
Rheumatology (Rheumatology Physician)
- Medicare participating
At a glance
- Medical school
- Philadelphia Col of Osteo Med, Sewanee (2017)
- Years since graduation
- 9
- In the NPI registry since
- 2017
- Medicare patients seen, 2024
- 607
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2017Medical school: Philadelphia Col of Osteo Med, Sewanee
- 2017Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
PA license OS021964 -
Internal Medicine Physician
PA license OT017580
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Geisinger Medical Center Danville, PA
- Lancaster General Hospital Lancaster, PA
- Reading Hospital West Reading, PA
- Penn State Health St. Joseph Reading, PA
- St Luke's Miners Memorial Hospital Coaldale, PA
Medical groups
- Phoenix Rehabilitation and Health Services Inc (2,800 clinicians)
- Arthritis and Osteoporosis Center, Inc. (7 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 607
- Services billed
- 128,399
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, denosumab, 1 mg | 7,020 | 75 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,044 | 97 |
| Established patient office or other outpatient visit, 30-39 minutes | 334 | 196 |
| Measurement of antibody for assessment of autoimmune disorder, any method | 168 | 24 |
| Established patient office or other outpatient visit, 20-29 minutes | 145 | 114 |
| Injection of drug or substance under skin or into muscle | 122 | 77 |
| X-ray of hand, 2 views | 87 | 46 |
| Insertion of needle into vein for collection of blood sample | 85 | 69 |
| Aspiration and/or injection of fluid from large joint | 76 | 50 |
| Infusion, normal saline solution, 250 cc | 58 | 24 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 14 companies reported 80 payments worth $1,746 in total to this clinician.
| Amgen Inc. | $312 |
|---|---|
| AbbVie Inc. | $280 |
| Novartis Pharmaceuticals Corporation | $216 |
| UCB, Inc. | $203 |
| AstraZeneca Pharmaceuticals LP | $186 |
| GlaxoSmithKline, LLC. | $112 |
| Janssen Biotech, Inc. | $109 |
| Lilly USA, LLC | $73.25 |
| Food and Beverage | $1,746 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.